| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, CFO And Treasurer | EVP &Chief Financial Officer | SVP, CFO &Treasurer +1 more
2 companies
Kelly James Patrick is an EVP &Chief Financial Officer at Vanda Pharmaceuticals Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2020 | VNDA Vanda Pharmaceuticals Inc. | EVP &Chief Financial Officer | Sell | 18,857 | $10.36 | $195,446.02 | -4.7% | |
| Jan 2, 2020 | VNDA Vanda Pharmaceuticals Inc. | EVP &Chief Financial Officer | Sell | 4,020 | $15.94 | $64,086.04 | -1.9% | |
| Mar 4, 2019 | VNDA Vanda Pharmaceuticals Inc. | EVP &Chief Financial Officer | Sell | 13,727 | $19.98 | $274,232.51 | -3.1% | |
| Jan 3, 2019 | VNDA Vanda Pharmaceuticals Inc. | EVP &Chief Financial Officer | Sell | 6,061 | $26.37 | $159,810.78 | -1.0% | |
| Mar 1, 2018 | VNDA Vanda Pharmaceuticals Inc. | EVP &Chief Financial Officer | Sell | 8,532 | $18.72 | $159,712.21 | -4.1% | |
| Jan 2, 2018 | VNDA Vanda Pharmaceuticals Inc. | EVP &Chief Financial Officer | Sale+OE | 9,155 | $15.35 | $140,493.55 | -5.2% | |
| Jan 3, 2017 | VNDA Vanda Pharmaceuticals Inc. | SVP, CFO &Treasurer | Sale+OE | 10,895 | $15.51 | $169,013.05 | -13.5% | |
| Jan 4, 2016 | VNDA Vanda Pharmaceuticals Inc. | SVP, CFO, Sec &Treasurer | Sale+OE | 9,564 | $8.96 | $85,693.44 | -13.6% | |
| Mar 10, 2015 | VNDA Vanda Pharmaceuticals Inc. | SVP, CFO, Sec &Treasurer | Sale+OE | 12,450 | $10.53 | $131,098.50 | -18.9% |